valentina iacobelli
机构: Sapienza University of Rome
每年引用次数
引用次数
引用: 5,706
H-指数: 33
I10-指数 : 53
出版物: 397
Temporary Uterine Artery Embolization Followed by Hysteroscopy to Treat a Case of Acquired Uterine Arteriovenous Malformation (UAVM): Case Report with Systematic Literature Review
Catena U , Romito I , Mastrovito S , Iacobelli V
Obstetrics and Gynecology Research 3 ( 2) 95 -118
2020
Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?
Sarah E Pinder , Rob I Nicholson , Ian O Ellis , John F Robertson
Clinical Cancer Research 10 ( 7) 2578 -2578
30
2004
Clinicopathological characteristics of basal-like breast cancer: a comparative study between Egyptian and British patients
Emad A Rakha , Andrew R Green , Ian O Ellis , Rabab Ahmed A Mohammed
Egyptian Journal of Pathology 39 ( 1) 115
2019
Abstract PS6-11: Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: Validation using a novel gene signature of HER2 activation
David M Heery , Ken Shirabe , Nigel P Mongan , Steffi Oesterreich
Cancer Research 81
2021
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases.
Elena Provenzano , Colin Purdie , Sarah E Pinder , Caterina Marchiò
British Journal of Cancer 124 ( 11) 1836 -1842
2021
PP1, PKA and DARPP-32 in breast cancer: A retrospective assessment of protein and mRNA expression.
Sarah J Storr , Emad A Rakha , Stewart G Martin , Andrew R Green
Journal of Cellular and Molecular Medicine 25 ( 11) 5015 -5024
2021
The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease
Phil Rolland , Zahra Madjd , Lindy Durrant , Ian O Ellis
Endocrine-related Cancer 14 ( 1) 73 -80
85
2007
Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer
Elgene Lim , Theresa A Hickey , Luke A Selth , Kee Ming Chia
Cancer Research 80
2020
Abstract P1-18-06: Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer
Sasagu Kurozumi , Andrew R Green , Ian O Ellis , Emad A Rakha
Cancer Research
2020
Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification
Andrew H S Lee , Heather P Key , Jane A Bell , Zsolt Hodi
Journal of Clinical Pathology 64 ( 6) 490 -492
25
2011
Re-audit of revised method for assessing the mitotic component of histological grade in needle core biopsies of invasive carcinoma of the breast.
Andrew H S Lee , Emad A Rakha , Zsolt Hodi , Ian O Ellis
Histopathology 60 ( 7) 1166 -1167
3
2012
Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments.
Fabrício F T Barros , Desmond G Powe , Ian O Ellis , Andrew R Green
Histopathology 56 ( 5) 560 -572
62
2010
Comparison of margin assessment by radial and shave sections in wide local excision specimens for invasive carcinoma of the breast.
Zsolt Hodi , Ian O Ellis , Christopher W Elston , Sarah E Pinder
Histopathology 56 ( 5) 573 -580
12
2010
Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens.
Tomás García-Caballero , Dorthe Grabau , Andrew R Green , John Gregory
Histopathology 56 ( 4) 472 -480
96
2010
Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation.
T’ng Chang Kwok , Emad A Rakha , Andrew H S Lee , Matthew Grainge
Histopathology 57 ( 2) 212 -219
36
2010
Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia
Emad A Rakha , Bernard C Ho , Veena Naik , Soumadri Sen
Histopathology 58 ( 4) 626 -632
45
2011
A review of the biological and clinical characteristics of luminal‐like oestrogen receptor‐positive breast cancer
Andrew R Green , Emad A Rakha , Ian O Ellis , Hany O Habashy
Histopathology 60 ( 6) 854 -863
16
2012
Histological grade of invasive carcinoma of the breast assessed on needle core biopsy - modifications to mitotic count assessment to improve agreement with surgical specimens.
Anne-Marie O’Shea , Emad A Rakha , Zsolt Hodi , Ian O Ellis
Histopathology 59 ( 3) 543 -548
24
2011
Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast.
Andrew H S Lee , Heather P Key , Jane A Bell , Zsolt Hodi
Histopathology 60 ( 6) 880 -884
37
2012
Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer
Jillian Davis , Stewart G Martin , Poulam M Patel , Andrew R Green
BMC Cancer 14 ( 1) 995 -995
12
2014